Leishmaniasis
- PMID: 17396274
- PMCID: PMC3202701
- DOI: 10.1136/pgmj.2006.047340corr1
Leishmaniasis
Abstract
Epidemiology, disease patterns, immunology, diagnosis, treatment and control measures of leishmaniasis are described. Various issues relating to leishmaniasis are highlighted: the relative lack of importance given to this disease compared with other infections, climate change and its possible impact on extension of endemicity of this infection, and new diagnostic tests which are improving diagnosis, especially in resource poor areas. Other important aspects discussed include the potential for newer oral therapy to change the way this disease is managed; Leishmania-HIV coinfection and groups at risk; and development of an effective vaccine.
Conflict of interest statement
Competing interests: None.
Corrected and republished from
-
Leishmaniasis.Postgrad Med J. 2006 Oct;82(972):649-57. doi: 10.1136/pgmj.2006.047340. Postgrad Med J. 2006. Corrected and republished in: Postgrad Med J. 2007 Feb;83(976):649-57. doi: 10.1136/pgmj.2006.047340corr1. PMID: 17068275 Free PMC article. Corrected and republished. Review.
References
-
- Murray H W. Kala-azar—progress against a neglected disease. N Engl J Med 2002. 22 1793 1794 - PubMed
-
- Guerin P J, Olliaro P, Sundar S. et al Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002. 2 494 501 - PubMed
-
- Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004. 27 305 318 - PubMed
-
- Herwaldt B L. Leishmaniasis. Lancet 1999. 354 1191 1199 - PubMed